Mirogabalin besylate
Huahana Huahana
Huahana Huahana
Nui Puke | Loaʻa | Kumukuai (USD) |
100mg | Loaʻa | 300 |
500mg | Loaʻa | 800 |
1g | Loaʻa | 1200 |
Nui hou aku | E kiʻi i nā huaʻōlelo | E kiʻi i nā huaʻōlelo |
Inoa Kimia:
((1R,5S,6S)-6-(carboxymethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)methanaminium benzenesulfonate
SMILES Code:
CCC(C1)=C[C@]2([H])[C@@]1([H])C[C@]2(CN)CC(O)=OO=S(C3=CC=CC =C3)(O)=O
Code InChi:
InChI=1S/C12H19NO2.C6H6O3S/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8;7-10(8,9) 6-4-2-1-3-5-6/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15);1-5H,(H,7,8 ,9)/t9-,10-,12-;/m1./s1
Ki InChi:
OKJXJRVWXYRSAN-TXULWXBWSA-N
huaʻōlelo:
Mirogabalin, Mirogabalin besylate, 1138245-21-2,1138245-13-2,DS-5565, DS5565, DS 5565
Hiki ke hoʻoheheʻe:DMSO;H2O
Waihona:
wehewehe:
ʻO Mirogabalin, i kapa ʻia ʻo DS-5565, he ligand α2δ-1 i hoʻomohala ʻia no ka ʻeha e pili ana i ka neuropathy peripheral diabetic, fibromyalgia, a me ka neuralgia postherpetic. Ua hōʻike ʻia nā hopena hoʻohiki i nā hoʻokolohua lapaʻau Phase II no ka mālama ʻana i ka ʻeha neuropathic peripheral diabetic.
Pahuhopu: α2δ-1